1. Optimizing efavirenz treatment: CYP2B6 genotyping or therapeutic drug monitoring?

   • Margalida Rotger
   • Amalio Telenti

   Editorial Commentary 11 January 2008 Pages: 335 - 336

2. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation

   • Thrasivoulos George Tzellos
   • Dimitrios Kouvelas

   Review Article 20 December 2007 Pages: 337 - 341

3. An independent contribution to the growth of paediatric clinical pharmacology in Italy

   • Maurizio Bonati

   Clinical Trial 03 January 2008 Pages: 343 - 346

4. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis

   • Jaroslav Chládek
   • Marie Simková
   • Martin Beránek

   Clinical Trial 29 December 2007 Pages: 347 - 355

   

5. High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe

   • Christopher Nyakutira
   • Daniel Röshammar
   • Collen Masimirembwa

   Pharmacogenetics 05 December 2007 Pages: 357 - 365

   

6. The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients

   • Charalampos Dragonas
   • Jan T. Wagner
   • Martin F. Fromm

   Pharmacogenetics 16 December 2007 Pages: 367 - 372

7. Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore

   • Shirley Kow Yin Kham
   • Chin Kok Soh
   • Allen Eng Juh Yeoh

   Pharmacogenetics 11 January 2008 Pages: 373 - 379

   

8. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes

   • Natasa Djordjevic
   • Roza Ghotbi
   • Eleni Aklillu

   Pharmacogenetics 22 December 2007 Pages: 381 - 385

   

9. Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity

   • Tobias Klaassen
   • Alexander Jetter
   • Uwe Fuhr

   Pharmacokinetics and Disposition 11 December 2007 Pages: 387 - 398

   

10. Ritodrine pharmacokinetics in twin pregnancy patients

    • A. Konda
    • A. Nodai
    • N. Inotsume

    Pharmacokinetics and Disposition 18 December 2007 Pages: 399 - 404

    

11. Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study

    • Ewoudt MW van de Garde
    • Henrik Endeman
    • Douwe H Biesma

    Pharmacoepidemiology and Prescription Open access 30 November 2007 Pages: 405 - 410

12. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine

    • Javier Garcia del Pozo
    • Alfonso Carvajal
    • Victorina Garcia del Pozo

    Pharmacoepidemiology and Prescription 20 December 2007 Pages: 411 - 415

    

13. Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden

    • G. Ringbäck Weitoft
    • Ö. Ericsson
    • M. Rosén

    Pharmacoepidemiology and Prescription 06 January 2008 Pages: 417 - 424

14. Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy

    • Elisabetta Poluzzi
    • Petar Strahinja
    • Nicola Montanaro

    Pharmacoepidemiology and Prescription 05 January 2008 Pages: 425 - 432

    

15. Diuretic drug therapy monitoring in the elderly: a cohort study

    • Marie Gérardin-Marais
    • Caroline Victorri-Vigneau
    • Pascale Jolliet

    Pharmacoepidemiology and Prescription 05 January 2008 Pages: 433 - 437

16. Use of desmopressin and concomitant use of potentially interacting drugs in elderly patients in Sweden

    • Rickard Ljung

    Pharmacoepidemiology and Prescription 08 January 2008 Pages: 439 - 444